Isolated metastasis of the ascending ramus of the mandible of thyroid follicular carcinoma: a case report
-
摘要: 滤泡性甲状腺癌(follicular thyroid carcinoma,FTC)是最常见的甲状腺癌之一,其发生率占所有甲状腺癌的10%~15%。FTC预后相对较好,但因其血运丰富,容易通过血道转移发生远处转移,其主要的转移部位为骨和肺,但是FTC的下颌骨转移较为少见。本文介绍了1例FTC术后21年转移至下颌骨升支,手术顺利完成,术后随访患者无复发。因患者术前无明显临床症状,给诊疗带来一定的困难。现通过提供详细的影像学和病理学图像探讨本病。Abstract: The mandibular metastatic spread of carcinoma from the thyroid gland is exceedingly rare. Follicular thyroid carcinoma is the second most common type of thyroid carcinoma, accounting for approximately 10% to 15% of all thyroid cancers. The prognosis of FTC is relatively satisfactory. Due to its rich blood transport, it is easy to metastasize hematological, with the main sites of metastasis are bone and lung. However, mandibular metastasis of thyroid follicular carcinoma is rare. We report a case of thyroid follicular carcinoma that metastasized to the ascending ramus of the mandible 21 years after surgery. The operation was successfully completed, and there was no recurrence during postoperative follow-up. Due to the absence of obvious clinical symptoms in the patient, the diagnosis and treatment were challenging. We have provided detailed radiographic and pathological images to facilitate understanding and discussion of the disease.
-
Key words:
- thyroid neoplasm /
- surgical procedures /
- bone metastasis
-
[1] Glaser C, Lang S, Pruckmayer M, et al. Clinical manifestations and diagnostic approach to metastatic cancer of the mandible[J]. Int J Oral Maxillofac Surg, 1997, 26(5): 365-368. doi: 10.1016/S0901-5027(97)80798-9
[2] D'Avanzo A, Treseler P, Ituarte PH, et al. Follicular thyroid carcinoma: histology and prognosis[J]. Cancer, 2004, 100(6): 1123-1129. doi: 10.1002/cncr.20081
[3] Haigh PI. Follicular thyroid carcinoma[J]. Curr Treat Options Oncol, 2002, 3(4): 349-354. doi: 10.1007/s11864-002-0034-z
[4] Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma[J]. J Nucl Med, 1996, 37(4): 598-605.
[5] Mihailovic J, Stefanovic L, Malesevic M. Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors[J]. Cancer Biother Radiopharm, 2007, 22(2): 250-255.
[6] Parameswaran R, Shulin Hu J, Min En N, et al. Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation[J]. Ann R Coll Surg Engl, 2017, 99(2): 151-154. doi: 10.1308/rcsann.2016.0300
[7] Kumar RV, Chakravarthy C, Sekhar GR, et al. Metastatic thyroid carcinoma presenting as hypervascular lesion of the mandible: a case report and review of literature[J]. J Oral Maxillofac Surg, 2010, 68(10): 2613-2616. doi: 10.1016/j.joms.2009.10.004
[8] Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jawbones: analysis of 390 cases[J]. J Oral Pathol Med, 1994, 23(8): 337-341. doi: 10.1111/j.1600-0714.1994.tb00072.x
[9] Bhadage CJ, Vaishampayan S, Umarji H. Mandibular metastasis in a patient with follicular carcinoma of thyroid[J]. Contemp Clin Dent, 2012, 3(2): 212-214. doi: 10.4103/0976-237X.96835
[10] Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview[J]. Eur J Cancer B Oral Oncol, 1995, 31B(6): 355-360.
[11] Zachariades N, Koumoura F, Vairaktaris E, et al. Metastatic tumors to the jaws: a report of seven cases[J]. J Oral Maxillofac Surg, 1989, 47(9): 991-996. doi: 10.1016/0278-2391(89)90386-8
[12] Kahn MA, McCord PT. Metastatic thyroid carcinoma of the mandible: case report[J]. J Oral Maxillofac Surg, 1989, 47(12): 1314-1316. doi: 10.1016/0278-2391(89)90732-5
[13] Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions[J]. Skeletal Radiol, 1985, 14(1): 10-19. doi: 10.1007/BF00361188
[14] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
[15] Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis[J]. Am J Surg, 1997, 174(5): 474-476. doi: 10.1016/S0002-9610(97)00158-X
[16] O'Neill CJ, Oucharek J, Learoyd D, et al. Standard and emerging therapies for metastatic differentiated thyroid cancer[J]. Oncologist, 2010, 15(2): 146-156. doi: 10.1634/theoncologist.2009-0190
[17] Min JJ, Chung JK, Lee Y, et al. Relationship between expression of the sodium/iodide symporter and(131) I uptake in recurrent lesions of differentiated thyroid carcinoma[J]. Eur J Nucl Med, 2001, 28(5): 639-645. doi: 10.1007/s002590100509
[18] Bodner L, Geffen DB. [Metastatic tumor of the jaw--diagnosis and management][J]. Refuat Hapeh Vehashinayim(1993), 2003, 20(1): 59-61, 81.
[19] Pruckmayer M, Glaser C, Marosi C, et al. Mandibular pain as the leading clinical symptom for metastatic disease: nine cases and review of the literature[J]. Ann Oncol, 1998, 9(5): 559-564. doi: 10.1023/A:1008286117771
[20] Liu L, Venkataraman G, Salhadar A. Follicular variant of papillary thyroid carcinoma with unusual late metastasis to the mandible and the scapula[J]. Pathol Int, 2007, 57(5): 296-298. doi: 10.1111/j.1440-1827.2007.02092.x